Principal Investigator Positions in Shanghai Immune Therapy Institute

Employer
Shanghai Immune Therapy Institute, Shanghai Jiao Tong University
Location
Shanghai (CN)
Salary
Generous salary and benefits
Posted
May 27 2021
Position Type
Full Time
Organization Type
Academia

Principal Investigator Positions in
Shanghai Immune Therapy Institute

I. About Shanghai Immune Therapy Institute

Shanghai Immune Therapy Institute (SITI), approved by Shanghai Municipal People’s Government in 2021, is jointly established and run by Shanghai Jiao Tong University School of Medicine (SJTUSM) and its affiliated Renji Hospital under the leadership of Dr. DONG Chen, world famous immunologist and Academician of the Chinese Academy of Sciences. SITI will gather advantages of both SJTUSM and Renji Hospital in basic and clinical advantages in immunology and integrate itself into the overall development outlook of State key laboratories in the Zhangjiang National Innovation Demonstration Zone and the Lingang free trade area in Pudong New District. Tumor immunotherapy, chronic inflammatory diseases and transplantation immunology, and infectious diseases and vaccines are the three major R&D and application areas for the institute.

SITI will make its share of contribution to the high-quality development of the biomedicine industry in Shanghai and the national strategy of Healthy China.  Phased goals for the institute include being built into a full-chain scientific research platform regarding immune-related diseases by 2025. It is also expected to become an R&D center with a group of internationally influential professionals in this field and with global influence.

By 2035, SITI is set to have an internationally leading position in the research fields of new drug targets, new mechanisms, antibody drug development, immunotherapy and other major immune-related diseases. It is expected to become a core element in Shanghai's world-class biomedical industry cluster, which is under construction, as well as in the city's independent innovation efforts.

About Renji Hospital

Renji Hospital, founded in 1844, is the first hospital practicing western medicine in Shanghai. It is a municipal hospital with a complete range of medical and surgical disciplines, integrating medical service, teaching and scientific researchserving as a university teaching hospital affiliated with SJTUSM. Renji has many departments in key disciplines, including Gastroenterology, Rheumatology and immunology, Urology, Obstetrics and Gynecology, Cardiology, Neurosurgery, General Surgery, Nephrology, Transplantation, Reproductive Medicine, Imaging Medicine, Allergy, Anesthesiology, Oncology, and Critical Care Medicine. All of them enjoy a high reputation at home and abroad. Today Renji has four campuses (in Eastern, Western, Northern and Southern Shanghai). The total number of approved beds in four campuses exceeds 2,250. By the end of 2020, the hospital had a total of nearly 3,500 full-time employees and 54 clinical medical technical departments. In 2020, Renji Hospital completed 4,965,800 outpatient and emergency services, 178,400 discharges, The hospital performed 162,000 inpatient operations, including 45,700 cases of key diseases, 65,800 cases of key operations, and 43,500 day surgeries. More than 800 surgeries were performed using the Da Vinci Robotics System. The average hospital stay was 5.45 days. Renji has achieved significant results in research with an annual scientific research funding exceeding 100 million yuan. In the past 10 years, more than 400 SCI papers have been published every year. Renji was honored with the National Science and Technology Progress Award, the Chinese Medical Science and Technology Award, and the Higher Education Science and Technology Progress Award. In August of 2019, Renji established a clinical research center to learn from the world's most advanced experiences, connecting with national strategies and promoting the development of clinical research.

Join us:  

SITI welcomes talents from both home and abroad to join us on this exciting journey of scientific exploration to improve human health. Posts available include Directors of Research Centers, and Principal Investigators (PI).

II. Research fields

Including but not limited to: 

  1. Tumor immunotherapy
  2. Chronic inflammatory diseases and transplantation immunology
  3. Infectious diseases and vaccines
  4. Systemic Immunology

III. Job Requirements

  1. PhD/MD in Immunology or relevant fields 
  2. Work experience in a world-renowned university/scientific research institute
  3. Internationally recognized expertise, remarkable achievements and academic influence, potential leaders in relevant fields

IV. We offer

  1. Competitive salary package, housing allowance and research start-up funds
  2. Access to health care and medical insurance
  3. Opportunities to turn basic research discoveries into translational research in close collaboration with clinical partners in Renji Hospital and other high-level hospitals affiliated to SJTUSM.  

V. Application procedure

To apply, please submit a single PDF file containing following materials (in English) to simi@shsmu.edu.cn

  1. Full CV with publication list or equivalent representative work
  2. A statement of research accomplishments and the future research plan (up to 3 pages)
  3. At least three reference letters